Insomnia: what is currently available

  • A Marais University of Pretoria
  • E Osuch Sefako Makgatho Health Sciences University
Keywords: insomnia, antidepressants, antihistamines, benzodiazepines, melatonin, non-benzodiazepines

Abstract

Insomnia is an important public health burden and is the most ubiquitous sleep disorder in the general population, requiring accurate diagnosis and effective treatment. Sleep hygiene and cognitive behavioural therapy form the foundation of management. In addition, various pharmacological entities are at hand to augment insomnia disorder. Acute insomnia requires short-term management with appropriately indicated hypnotic agents, while chronic sleeping difficulties benefit more from antidepressants. This article informs the reader about the currently available sleeping agents in South Africa, and may not include more effective or potent agents used inĀ other parts of the world that are not yet accessible for local prescription.

Author Biographies

A Marais, University of Pretoria

Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, South Africa

E Osuch, Sefako Makgatho Health Sciences University

Department of Pharmacology and Therapeutics, School of Medicine, Sefako Makghato Health Sciences University, South Africa

Published
2020-04-17
Section
Review